Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The rapidly growing incidences of cardiac disorders along with demand for minimally invasive treatment due to less complication, changing lifestyle and rise in older population are the prime drivers for the interventional cardiology devices market. Moreover, increasing awareness among the patient population in developing countries along with favorable government initiatives and technical advancements has led to the increased importance of this market.
The high cost of the devices, many entry barriers, and stringent government policies put constraints on the market.
Market Segmentation
The market is segmented by type of products (Catheters, Balloons (Scoring balloons, Cutting balloons and Drug Eluting balloons), Stents (Bare Metal stents, Drug Eluting Stents and Bioresorbable Stents), Guidewires, Vascular Closure Devices and Atherectomy Devices), by end users (ASCs, Hospitals, Physicians' office) and by region (North America, Europe, Asia-Pacific and the Rest of the World).
Geographic Analysis
North America leads the interventional cardiology devices market followed by Europe. Moreover, Asia-Pacific region is expected to grow rapidly due to rising population and technological development.
Key Players
Some of the major players in the market include Abbott Vascular, Boston Scientific, Cordis, Medtronic, St. Jude Medical and Lombard Medical Inc.
The report contains comprehensive analysis on:
--> Interventional Cardiology Devices Market Segments
--> Interventional Cardiology Devices Market Drivers, Restraints and Opportunities
--> Interventional Cardiology Devices Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Interventional Cardiology Devices Market Current Trends
--> Competition & Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Interventional Cardiology Devices Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...